Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Cancer Research|May 15, 1995
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancerH Yu, M Giai, E P Diamandis, et al.
Genes, Chromosomes & Cancer|August 1, 1993
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancersC Theillet, J Adelaide, G Louason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian studyF Boccardo, A Rubagotti, A Perrotta, et al.
Breast (Edinburgh, Scotland)|October 12, 2014
Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgeryN Biglia, R Ponzone, V E Bounous, et al.
Breast Cancer Research and Treatment|April 1, 1988
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patientsS Iacobelli, E Arno, P Sismondi, et al.
Breast Cancer Research and Treatment|January 1, 1985
Prognostic value of estrogen receptors determined by radiochemical vs. histochemical methods in breast cancerP Sismondi, V Aimone, F Genta, et al.
Cancer Investigation|January 1, 1997
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROCTA)F Boccardo, A Rubagotti, D Amoroso, et al.
International Journal of Cancer|May 16, 1998
Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patientsM A Levesque, D Katsaros, H Yu, et al.
Tumori|August 31, 1985
Early detection of breast cancer recurrences through periodic follow-up--is it useless?S Ciatto, M Rosselli Del Turco, P Pacini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancerR Ponzone, F Montemurro, F Maggiorotto, et al.
Pageof 11